USP17L2 and diffuse large B-cell lymphoma: Levels of DUB3, SPOP and TRIM33/24, previously reported to be involved in regulating sensitivity to BETis [44–46], were neither significantly different nor altered by OTX015 treatment in the three RT-DLBCL cells (Fig. S5A).